Pharmaceutical Business review

Immucor names new CFO

Mr Flynt is a certified public accountant with more than 25 years of financial management experience. He has most recently served as vice president, finance, with McKesson in Alpharetta, Georgia.

US-based Immucor, which provides automated instrument-reagent systems to the blood transfusion industry, has previously announced that current CFO Patrick Waddy intended to resign for family reasons but had agreed to remain until a replacement was hired. Mr Waddy now becomes the company’s vice president of International Finance, reporting to Mr Flynt, and will assist in the transition.

Gioacchino De Chirico, president and CEO of Immucor, said: “We are extremely pleased to have found an individual with the experience that Rick Flynt brings to the company. In particular, we were attracted by his strong background in public accounting, his expertise in dealing with complex accounting issues, and his experience as a senior financial executive with publicly-held companies.”